# John Ravits

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-ravits/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,853 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 58 |
| i10-index | 118 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5083309896 |
| ORCID iD | https://orcid.org/0000-0001-6521-4649 |
| Works | 183 |

## Researcher papers

- [Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways](https://scholariq.org/papers/exome-sequencing-in-amyotrophic-lateral-sclerosis-identifies-risk-genes-and/)
- [Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial](https://scholariq.org/papers/efficacy-of-minocycline-in-patients-with-amyotrophic-lateral-sclerosis-a-phase/)
- [RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS](https://scholariq.org/papers/ripk1-mediates-axonal-degeneration-by-promoting-inflammation-and-necroptosis-in/)
- [Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALS](https://scholariq.org/papers/phase-1-2-trial-of-antisense-oligonucleotide-tofersen-for-i-sod1-i-als/)
- [Controversies and priorities in amyotrophic lateral sclerosis](https://scholariq.org/papers/controversies-and-priorities-in-amyotrophic-lateral-sclerosis/)
- [TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A](https://scholariq.org/papers/tdp-43-loss-and-als-risk-snps-drive-mis-splicing-and-depletion-of-unc13a/)
- [A revision of the El Escorial criteria - 2015](https://scholariq.org/papers/a-revision-of-the-el-escorial-criteria-2015/)
- [Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia](https://scholariq.org/papers/postmortem-cortex-samples-identify-distinct-molecular-subtypes-of-als/)
- [Primary lateral sclerosis: consensus diagnostic criteria](https://scholariq.org/papers/primary-lateral-sclerosis-consensus-diagnostic-criteria/)
- [Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS](https://scholariq.org/papers/validation-of-serum-neurofilaments-as-prognostic-and-potential-pharmacodynamic/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Prion Diseases and Protein Misfolding](https://scholariq.org/topics/prion-diseases-and-protein-misfolding/)
- [RNA Research and Splicing](https://scholariq.org/topics/rna-research-and-splicing/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.